GLP-1 drugs, fat loss compounds & metabolic agents.
GSBR-1290
NN 9487
Pramlintide, amylin analog, IAPP agonist
AOD9604, HGH fragment 176-191, Anti-Obesity Drug 9604
AM833, cagri
GW-501516, GW1516, endurobol
Trulicity, GLP-1 agonist
methylliberine
Byetta, Bydureon, GLP-1 agonist
GW-0742, GW-501516 analog
L-carnitine, carnitine, LCLT
Saxenda, Victoza
AMG 133; MariTide (development brand name)
ORG 55001, GLP-1/GIP coagonist
Glucophage, biguanide, antidiabetic
INV-202, MRI-1891, S-MRI-1891
mitochondrial open reading frame of the twelve S rRNA-c, mit
MK-0941, GIP agonist
Sirolimus, mTOR inhibitor, immunosuppressant
LY3437943, GGG tri-agonist
Ozempic, Wegovy, Rybelsus (brand names)
Stenabolic, SR-9009
SR-9011
LY3437943, GLP-1/glucagon coagonist
oxedrine, p-synephrine, bitter orange alkaloid
Egrifta, TH9507, tesamorelin acetate
NS2330, triple monoamine reuptake inhibitor
Mounjaro, Zepbound (brand names)
UBT-251; GLP-1/GIP/glucagon triple agonist (United Bio-Techn
alpha-adrenergic antagonist, yohimbe alkaloid
No compounds match that risk filter.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.